Executive Summary
Developed a public comps framework to benchmark valuation multiples, assess relative market positioning, and compare operating and capital structure differences across a relevant peer set.
Objective
To establish a relative valuation framework that contextualises Smith & Nephew's market valuation against comparable medical device companies.
Approach
- —Identified relevant peer group based on business model and market positioning
- —Compiled trading multiples across EV/Revenue, EV/EBITDA, and P/E metrics
- —Analysed drivers of multiple differences including growth, margins, and capital intensity
- —Assessed implied valuation range and market positioning
Key Outputs
- —Trading comparables analysis with peer benchmarking
- —Multiple comparison and driver analysis
- —Implied valuation range assessment
- —Peer group financial summary
Commercial Insight
Relative valuation requires careful peer selection and understanding of why multiples differ. Premium multiples are typically justified by superior growth, margins, or capital efficiency rather than sector membership alone.
Tools & Methods
ExcelCapital IQAnnual ReportsMarket Data
Full materials available upon request.
Next Project
National Grid – Precedent Transactions→